SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001561743-18-000034
Filing Date
2018-04-25
Accepted
2018-04-25 16:09:31
Documents
5
Period of Report
2018-04-24
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2018definitiveproxystatem.htm DEF 14A 991849
2 a2018proxycarda.jpg GRAPHIC 141184
3 a2018proxycardb.jpg GRAPHIC 197281
4 proxycardaa03.jpg GRAPHIC 274715
5 proxycardca03.jpg GRAPHIC 39139
  Complete submission text file 0001561743-18-000034.txt   1880923
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36225 | Film No.: 18774441
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1